Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
Journal of Medicinal Chemistry · 13.02.2025 · 68 (3) · 2301-2306
DOI: 10.1021/acs.jmedchem.4c02647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.02.2025. Verfasst von Eric L Schneider und 3 weiteren Autor:innen. Beteiligte Einrichtung: ProLynx, Inc., 135 Mississippi Street, San Francisco, California 94107, United States. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ProLynx, Inc., 135 Mississippi Street, San Francisco, California 94107, United States.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143, United States.
ORCID-Profile: Eric L Schneider, John A Hangasky, Daniel V Santi
Zitieren
APA
Schneider, E. L., Hangasky, J. A., Ashley, G. W., & Santi, D. V. (2025). Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides. Journal of Medicinal Chemistry, 68(3), 2301-2306. https://doi.org/10.1021/acs.jmedchem.4c02647
Vancouver
Schneider EL, Hangasky JA, Ashley GW, Santi DV. Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides. Journal of Medicinal Chemistry. 2025;68(3):2301-2306. doi:10.1021/acs.jmedchem.4c02647
BibTeX
@article{Schneider2025,
author = {Schneider, Eric L and Hangasky, John A and Ashley, Gary W and Santi, Daniel V},
title = {Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {3},
pages = {2301--2306},
doi = {10.1021/acs.jmedchem.4c02647}
}
EUVIMED